EGFR and hepatocellular carcinoma: The cells harboring EGFR activating mutations (NCI-H3255, HCC-827 and PC9) were the most sensitive to all the EGFR-TKIs, and had the highest expression levels of both miR-21 and phospho-EGFR (Figure 5A).